FDA recall record

Lacosamide Oral Solution, USP, CV, 10mg/mL recall — FDA D-0094-2023

Failed Excipient Specifications: out of specification result observed for p-Hydroxybenzoic Acid content

Class IIIclassification
D-0094-2023official record ID
Dec 21, 2022report date

Recall record at a glance

Official recordD-0094-2023
CategoryDrug Recalls
ClassificationClass III
FDA record statusTerminated
Recalling firmCamber Pharmaceuticals, Inc.
Report dateDec 21, 2022
Recall initiation dateDec 6, 2022
QuantityN/A
LocationPiscataway, NJ, United States

Official product description

Lacosamide Oral Solution, USP, CV, 10mg/mL, packaged in 200 mL bottle, Rx Only, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, Manufactured By: HETERO LABS LIMITED, Jeedimetla, Hyderabad - 500 055, India, NDC 31722-627-26

Why the product was recalled

Failed Excipient Specifications: out of specification result observed for p-Hydroxybenzoic Acid content

Distribution information

USA Nationwide

How to read the classification

FDA Class III generally covers situations in which use of or exposure to the product is not likely to cause adverse health consequences. The classification displayed here is taken from the FDA enforcement record.

Additional record details

Recall type: Voluntary: Firm initiated. Initial notification: Letter.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.

Related recall records

Other records from the same recalling company are shown first when available.